Dr. Joseph McGuirk, MD
Claim this profileThe University of Kansas Hospital
Affiliated Hospitals
The University Of Kansas Hospital
University Of Kansas Medical Center Research Institute Inc
Clinical Trials Joseph McGuirk, MD is currently running
Gamma Delta T-cell Therapy
for Leukemia
Gamma delta T-cells are part of the innate immune system with the ability to recognize malignant cells and kill them. This study uses gamma delta T-cells to maximize the anti-tumor response and minimize graft versus host disease (GVHD) in leukemic and myelodysplastic patients who have had a partially mismatched bone marrow transplant (haploidentical).
Recruiting
1 award
Phase 1
OrcaGraft
for Blood Cancer
This trial is testing the safety and effectiveness of using specially prepared donor cells for patients with blood cancers. These patients are receiving a strong type of bone marrow transplant. The goal is to replace their damaged bone marrow with healthy cells from a donor to help them recover. Bone marrow transplantation (BMT) is a powerful strategy for the treatment of leukemia, aplastic anemia, congenital immunodeficiency, and autoimmune diseases.
Recruiting
1 award
Phase 1
More about Joseph McGuirk, MD
Clinical Trial Related
6 years of experience running clinical trials · Led 9 trials as a Principal Investigator · 3 Active Clinical Trials
Treatments Joseph McGuirk, MD has experience with
- MSCTC-0010
- Orca-T
- CRG-022
- CTX110
- AUTO1
- EAGD T-cell Infusion
Breakdown of trials Joseph McGuirk, MD has run
Acute Lymphoblastic Leukemia
Myelodysplastic Syndrome
Acute Myeloid Leukemia
Cutaneous T-Cell Non-Hodgkin Lymphoma
Graft-versus-Host Disease
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Joseph McGuirk, MD specialize in?
Joseph McGuirk, MD focuses on Acute Lymphoblastic Leukemia and Myelodysplastic Syndrome. In particular, much of their work with Acute Lymphoblastic Leukemia has involved treating patients, or patients who are undergoing treatment.
Is Joseph McGuirk, MD currently recruiting for clinical trials?
Yes, Joseph McGuirk, MD is currently recruiting for 3 clinical trials in Kansas City Kansas. If you're interested in participating, you should apply.
Are there any treatments that Joseph McGuirk, MD has studied deeply?
Yes, Joseph McGuirk, MD has studied treatments such as MSCTC-0010, Orca-T, CRG-022.
What is the best way to schedule an appointment with Joseph McGuirk, MD?
Apply for one of the trials that Joseph McGuirk, MD is conducting.
What is the office address of Joseph McGuirk, MD?
The office of Joseph McGuirk, MD is located at: The University of Kansas Hospital, Kansas City, Kansas 66160 United States. This is the address for their practice at the The University of Kansas Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.